GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Solta Medical Inc (SLTM) [hlAlert]

Rating:
Buy SLTM
down 30.80 %

Thermage, Inc. (SLTM) rated Buy by Pacific Growth Equities

Posted on: Tuesday,  Jan 29, 2008  10:25 AM ET by Pacific Growth Equities

Pacific Growth Equities rated Buy Solta Medical Inc (NASDAQ: SLTM) on 01/29/2008, when the stock price was $4.22.
Since then, Solta Medical Inc has lost 30.81% as of 01/22/2014's recent price of $2.92.
If you would have followed this Pacific Growth Equities's recommendation on SLTM, you would have lost 30.8% of your investment in 2185 days.

Solta Medical Inc., formerly Thermage, Inc. is engaged in designing, developing, manufacturing and marketing energy-based medical device systems for aesthetic applications. These systems are marketed under the brand names Fraxel and Thermage and are Food & Drug Administration (FDA) cleared for dermatological procedures in the applications, which include: Skin Tightening, the Thermage NXT system offers non-invasive treatment options for skin tightening and contouring, body shaping, and improvement in the appearance of cellulite; Skin Rejuvenation, the Fraxel re:fine and Fraxel re:store systems offer treatments for skin conditions such as fine lines and pigmentation.

The Pacific Growth Equities research department strives to stay ahead of breaking news in some of the fastest moving and most complicated industries on Wall Street. Our research names are affected not only by economic swings but also by specific government regulations, new legislation, and often public opinion. Staying on top of every nuance allows us—and our clients—to lead and not follow. We take pride in providing incremental, value-added insights to the global institutional investment community. Our analysts are experienced in both industry and Wall Street, and are empowered to make the tough calls. Research insights are delivered quickly to the appropriate decision-makers so that important investment opportunities will not be lost. Any research analyst can call an impromptu meeting when news is breaking, to keep the sales force and management abreast of events that could impact the market both from a macro point of view and from one that is stock-specific.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/29/2008 10:25 AM Buy
None
4.22
as of 12/24/2008
1 Week down  -23.27 %
1 Month up  18.66 %
3 Months down  -33.58 %
1 YTD down  -42.94 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy